Nico G. Hartwig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nico G. Hartwig has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Florens G. A. Versteegh
Department of Pediatrics, Groene Hart Ziekenhuis, Gouda, the Netherlands
2 shared publications - Jérôme O. Wishaupt
Department of Paediatrics, Reinier de Graaf Hospital, Delft, the Netherlands
2 shared publications - Gertrude van Den Brink
Department of Pediatrics, ErasmusMC-Sophia, Wytemaweg 80 3015 CN, Rotterdam, The Netherlands.
1 shared publication - Jacob C Douma
Centre for Crop System Analysis, Wageningen University and Research Centre, Wageningen, The Netherlands
1 shared publication - Léon Winkel
Department of Pediatrics, Kennemer Hospital, Postbus 417, Haarlem 2000 AK, The Netherlands
1 shared publication - Ma van Houten
Department of Pediatrics, Spaarne Hospital, Postbus 770, Hoofddorp 2130 AT, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 30 September 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 526
Bordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study
The incidence of pertussis has been increasing worldwide. In the Netherlands, the seroprevalence has risen higher than the reported cases, suggesting that laboratory tests for pertussis are considered infrequently and that even more pertussis cases are missed. The objective of our study was to determine the frequency of pertussis in clinically unsuspect cases compared to suspect cases with the intention of finding clinical predictors. The present prospective cohort study was part of a controlled clinical trial evaluating the impact of molecular diagnostics on clinical decision making in pediatric respiratory infections, performed during 2 winter seasons. For this study, in the first season pertussis was only tested in case of clinical suspicion, in the second season, pertussis was also tested without clinical suspicion. Multivariate and univariate analysis were performed using SPSS 18 and Statistical software ‘R’. In the two seasons respectively 22/209 (10,5%) and 49/373 (13,1%) cases were clinically suspected of pertussis. Bordetella pertussis was detected by real time RT-PCR in respectively 2/22 (9,1%) and 7/49 (14,3%) cases. In the second season an additional 7 cases of pertussis were found in clinically unsuspected cases (7/257 = 2,7%). These additional cases didn’t differ in clinical presentation from children without a positive test for pertussis with respect to respiratory symptoms. Pertussis in children sometimes mimics viral respiratory tract infections. If pertussis diagnostics are based on clinical suspicion alone, about 1 in 5 cases (19%) is missed. Despite widely accepted clinical criteria, paroxysmal cough is not a good predictor of pertussis. To prevent spreading, physicians should include B. pertussis in routine diagnostics in respiratory tract infections.
- 30 September 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 526
Open AccessBordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study
The incidence of pertussis has been increasing worldwide. In the Netherlands, the seroprevalence has risen higher than the reported cases, suggesting that laboratory tests for pertussis are considered infrequently and that even more pertussis cases are missed. The objective of our study was to determine the frequency of pertussis in clinically unsuspect cases compared to suspect cases with the intention of finding clinical predictors. The present prospective cohort study was part of a controlled clinical trial evaluating the impact of molecular diagnostics on clinical decision making in pediatric respiratory infections, performed during 2 winter seasons. For this study, in the first season pertussis was only tested in case of clinical suspicion, in the second season, pertussis was also tested without clinical suspicion. Multivariate and univariate analysis were performed using SPSS 18 and Statistical software ‘R’. In the two seasons respectively 22/209 (10,5%) and 49/373 (13,1%) cases were clinically suspected of pertussis. Bordetella pertussis was detected by real time RT-PCR in respectively 2/22 (9,1%) and 7/49 (14,3%) cases. In the second season an additional 7 cases of pertussis were found in clinically unsuspected cases (7/257 = 2,7%). These additional cases didn’t differ in clinical presentation from children without a positive test for pertussis with respect to respiratory symptoms. Pertussis in children sometimes mimics viral respiratory tract infections. If pertussis diagnostics are based on clinical suspicion alone, about 1 in 5 cases (19%) is missed. Despite widely accepted clinical criteria, paroxysmal cough is not a good predictor of pertussis. To prevent spreading, physicians should include B. pertussis in routine diagnostics in respiratory tract infections.
- 4 August 2014
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 16 (1) , 43-48
PCR testing for Paediatric Acute Respiratory Tract Infections
- 4 August 2014
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 16 (1) , 43-48
PCR testing for Paediatric Acute Respiratory Tract Infections
- Open Access
- 26 April 2013
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 112
Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
The cost-effectiveness of universal rotavirus (RV) vaccination is controversial in developed countries. As a result, RV vaccination programs do not currently exist in most European countries. Hospitalization is the main driver of RV disease costs, and prematurity, low birth weight (LBW) and underlying medical conditions have been associated with RV hospitalization and complications. We investigated the cost-effectiveness of targeted RV vaccination of high-risk infants and universal RV vaccination versus no vaccination.
- 26 April 2013
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 112
Open AccessTargeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
The cost-effectiveness of universal rotavirus (RV) vaccination is controversial in developed countries. As a result, RV vaccination programs do not currently exist in most European countries. Hospitalization is the main driver of RV disease costs, and prematurity, low birth weight (LBW) and underlying medical conditions have been associated with RV hospitalization and complications. We investigated the cost-effectiveness of targeted RV vaccination of high-risk infants and universal RV vaccination versus no vaccination.